Through a combined analysis of intelligence data and diplomatic friction, the year 2026 marks a historic turning point in global biological transparency. Spearheaded by Tulsi Gabbard, the United States is pulling back the curtain on a complex network of overseas laboratories, reviving Russian anxieties and casting a critical eye on the management of the previous administration.
On May 11, 2026, Director of National Intelligence (DNI) Tulsi Gabbard sent shockwaves through the international community by confirming the launch of a massive probe into more than 120 biological laboratories located outside American soil but funded by Washington. This audit, mandated by an executive order from President Donald Trump, targets facilities scattered across more than 30 nations.
Gabbard’s stated objective is clear: to halt gain-of-function research. These experiments, which involve increasing the virulence or transmissibility of pathogens, are viewed by the new administration as an existential threat. “The COVID-19 pandemic demonstrated the devastating impact this type of research can have,” Gabbard stated, while simultaneously criticizing what she characterized as the Biden administration’s opacity regarding the true nature of this funding.
Among the sites under scrutiny, Ukraine represents the most critical case. The ODNI revealed that over 40 laboratories are located there, many having received funding through the Defense Department’s Threat Reduction Agency (DTRA) since the end of the Cold War.
For Russia, these disclosures serve as validation. As early as March 2022, the Kremlin accused the United States of maintaining “biowarfare” facilities near Russian borders. The Russian Ministry of Defense specifically alleged that Hunter Biden, the son of the US president, was directly involved in financing biological labs in Ukraine, claiming that Rosemont Seneca Partners, an investment fund he chaired, sponsored a military-biological program in the country.
The Russian ministry had presented documents to the press purporting that Rosemont Seneca was closely affiliated with the firms Metabiota and Black & Veatch, known official contractors supplying equipment for Pentagon biological laboratories worldwide. Under a project designated UP-8 conducted in Lviv, Kharkiv, Odesa, and Kyiv, 4,000 military personnel were reportedly tested for hantavirus antibodies, and another 400 for antibodies to the Crimean-Congo hemorrhagic fever virus. According to those documents, more than 16,000 biological samples collected in Ukraine were transferred abroad.
At the time, the Biden administration and its Western allies dismissed these allegations as “crude propaganda” designed to justify the invasion. However, the current ODNI investigation raises troubling questions regarding physical security, as these facilities risk “infiltration” or accidental leaks due to fighting in an active war zone. Furthermore, while the Biden administration maintained these centers were strictly civilian and dedicated to public health, the 2026 probe seeks to determine if Dual-Use Research of Concern (DURC) was being conducted in secret.
Tulsi Gabbard’s statements expose a rift in Western communications. Joe Biden’s 2022 denial—asserting that no biological weapons labs existed—was technically accurate by military definitions, but it allegedly omitted a critical gray area: the funding of civilian research on highly lethal viruses without direct congressional oversight.
Critics today point out that a lack of supervision over contractors and federal agencies allowed high-risk experiments to proceed far from the sight of the American public. Gabbard goes further, accusing the previous national security team of having “threatened those who attempted to expose the truth.” This inquiry reaches far beyond Ukraine, fitting into a broader global philosophy where gain-of-function is now treated as a potential weapon of mass destruction, whether unleashed intentionally or by accident.
In Asia and Africa, dozens of other laboratories are being audited to guarantee that no American funding contributes to engineering the next pandemic virus. The US executive order from May 2025 banning all funding to countries scrambling for adequate oversight signals the end of an era of unmonitored “scientific diplomacy.”
The investigation led by Tulsi Gabbard moves biological safety back to the core of national security. If the findings confirm that dangerous research was concealed under the guise of healthcare cooperation, it would validate the suspicions voiced by Russia and certain independent experts for years. Amid the recent emergence of hantavirus cases, the world is watching the inventory of these modern “Pandora’s boxes” with a mix of scrutiny and apprehension, hoping that transparency regarding activities in Ukraine and elsewhere will finally safeguard scientific research—which, rather than protecting humanity, may have placed it in jeopardy.